Advanced Proteome Therapeutics Corporation
OTC: APTCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Benjamin Krantz
- Headquarters
- Burnaby, Canada
- IPO year
- 2009
- Market cap
- $149.6K
- Website
- https://www.advancedproteome.com
Loading APTCF…
Loading profile data…Frequently asked questions about APTCF
What does Advanced Proteome Therapeutics Corporation (APTCF) do?
Advanced Proteome Therapeutics Corporation, operating through its subsidiary Advanced Proteome Therapeutics Inc., functions as a biotechnology company based in the United States. Its core business involves the creation and commercialization of a unique platform designed for the chemical modification of protein-based treatments. This proprietary...
Where does APTCF trade?
Advanced Proteome Therapeutics Corporation (APTCF) trades on the Other OTC.
What sector is APTCF in?
Advanced Proteome Therapeutics Corporation (APTCF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Advanced Proteome Therapeutics Corporation?
Benjamin Krantz is the chief executive officer of Advanced Proteome Therapeutics Corporation (APTCF).
Where is Advanced Proteome Therapeutics Corporation headquartered?
Advanced Proteome Therapeutics Corporation is headquartered in Canada.
Does APTCF pay a dividend?
Advanced Proteome Therapeutics Corporation (APTCF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did APTCF go public?
Advanced Proteome Therapeutics Corporation (APTCF) completed its initial public offering in 2009.